MedDataX Logo

Kinesiotape on Quadriceps and Gluteus in Counter Movement Jump and Sprint in Soccer Players

NCT ID: NCT04635982

Last Updated: 2020-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-02

Study Completion Date

2018-03-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to analyse the effect of KT on countermovement jump (CMJ) and sprint immediately and 24 hours after its application on the quadriceps and gluteus maximus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Kinesiotape (KT) is a technique commonly used in sports practice. It may be beneficial in enhancing muscle function by additional cutaneous afferent stimulation. The objective of this study was to analyze the effect of KT on countermovement jump (CMJ) and 20-m sprints immediately and 24 hours after its application on the quadriceps and gluteus maximus. A total of 37 male soccer players (19.7 ± 0.9 years old) were randomly assigned to one of 3 groups: experimental group: KT activation (KTact), placebo group: sham tape (KTst), and control group (CG). Participants performed a 30-minute preliminary warm-up, after which they conducted CMJ and 20-m sprint tests. These tests were repeated later (with KT application or not) and after 24 hours.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sports Physical Therapy Athletics Performance

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Kinesiotape Soccer Sprint

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Thirty-seven subjects were randomly allocated to the different study groups using the software AleatorMetod.xls. Subjects were divided into three groups: 13 subjects were assigned to the experimental group with KT activation (KTact); 12 subjects, to the placebo group with a sham tape KT (KTst); and 12 subjects, to the control group (CG).
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo Group

With regard to the Kinesiotape technique, 2 I-shaped tapes were placed at the quadriceps, following the same direction of the muscle fibres and with no tension. At the gluteus, 2 I-shaped tapes were applied following the same direction of the muscle fibres and with no tension.

Group Type PLACEBO_COMPARATOR

Kinesiotape of the physical performance

Intervention Type OTHER

It has done a countermovement vertical jump, a twenty meter sprint and a kinesio tape application technique

Experimental Group

In rectus femoris, origin was under the anterosuperior iliac spines, and taping finished with a Y-shape pattern under the patella. After that, an I-shaped KT was applied over vastus medialis and vastus lateralis muscles in both quadriceps. Finally, subjects were taped with a Y-shaped KT at the gluteus maximus muscles. Tape tension was between 25% and 50%.

Group Type EXPERIMENTAL

Kinesiotape of the physical performance

Intervention Type OTHER

It has done a countermovement vertical jump, a twenty meter sprint and a kinesio tape application technique

Control Group

It has not done any intervention in this group.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesiotape of the physical performance

It has done a countermovement vertical jump, a twenty meter sprint and a kinesio tape application technique

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* soccer players;
* age of 18-25 years;
* a regular attendance at training sessions

Exclusion Criteria

* history of L1-L5 radiculopathy or lumbo-sacral pathology ;
* any treatment with KT on quadriceps or gluteus in the month prior to the study;
* history of systemic diseases that may affect the nervous system, musculoskeletal injuries or surgeries in the lower limb during the year prior to the study;
* use of analgesics or nonsteroidal anti-inflammatory drugs.
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Católica San Antonio de Murcia

OTHER

Sponsor Role collaborator

Universidad de Murcia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Javier Reina Abellan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Javier Reina Abellan, PhD

Role: PRINCIPAL_INVESTIGATOR

Universidad Católica San Antonio de Murcia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maria Cinta Gomez

Valencia, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

48490314N

Identifier Type: -

Identifier Source: org_study_id